The emergence of COVID-19 infection led to the indiscriminate use of antimicrobials without
knowing their efficacy in treating the disease. The gratuitous use of antibiotics for COVID-19 …

The reduction in infectious disease morbidity and mortality may be attributed to a variety of
factors; however, improved sanitation and public health, and the introduction of vaccines …

Background: The first wave of COVID-19 pandemic may have significantly impacted
antimicrobial consumption in hospitals. The objective of this study was to assess the …

Since first identified in late 2019, the acute respiratory syndrome coronavirus (SARS-CoV2)
and the resulting coronavirus disease (COVID-19) pandemic has overwhelmed healthcare …

The net effect of the coronavirus disease 2019 (COVID-19) pandemic and the response to it
on the emergence of antimicrobial resistance is yet unknown. Positive impacts on the spread …

Abstract Introduction: Coronavirus disease 2019 (COVID-19) results in similar clinical
characteristics as bacterial respiratory tract infections and can potentially lead to antibiotic …

Background: Antimicrobials have been widely used during the COVID-19 pandemic. This
study aimed to analyze the impact of the COVID-19 pandemic on the antimicrobial …

We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19).
Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide …

The COVID-19 pandemic is expected to worsen the global problem of antimicrobial
resistance (AMR). There is a heightened interest in understanding this effect and to develop …

The global COVID-19 pandemic has resulted in an upsurge in antimicrobial use. The
increase in use is multifactorial, and is particularly related to the empirical treatment of SARS …